Ocular Therapeutix
OCUL
#4792
Rank
ยฃ1.46 B
Marketcap
ยฃ6.73
Share price
2.81%
Change (1 day)
12.85%
Change (1 year)

Revenue for Ocular Therapeutix (OCUL)

Revenue in 2024: ยฃ50.77 Million

According to Ocular Therapeutix's latest financial reports the company's current revenue (TTM ) is ยฃ40.98 Million. In 2024 the company made a revenue of ยฃ50.77 Million an increase over the revenue in the year 2023 that were of ยฃ45.87 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ocular Therapeutix from 2014 to 2024

Annual revenue

Year Revenue Change
2024ยฃ50.77 M10.69%
2023ยฃ45.87 M7.78%
2022ยฃ42.56 M32.01%
2021ยฃ32.24 M152.53%
2020ยฃ12.76 M296.08%
2019ยฃ3.22 M105.62%
2018ยฃ1.56 M10.18%
2017ยฃ1.42 M-6.96%
2016ยฃ1.52 M29.5%
2015ยฃ1.18 M138.15%
2014ยฃ0.49 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
SurModics
SRDX
ยฃ88.75 M 116.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
ยฃ59.44 M 45.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
ยฃ78.43 M 91.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
ยฃ0.97 B 2,280.38%๐Ÿ‡บ๐Ÿ‡ธ USA